University of Maryland Charles Regional Medical Center Now Offering High-Tech Prostate Imaging and Biopsy
For more information about UM Charles Regional Imaging and MRI/ultrasound fusion biopsy, please call 301-539-0345 or visit CharlesRegionalImaging.com.
University of Maryland Charles Regional Medical Center (UM CRMC) is proud to introduce a powerful, new MRI solution for secondary evaluation, planning, and targeted biopsy of the prostate. The UroNav Fusion Biopsy System fuses MRI and Ultrasound images to help physicians see suspicious tumors in real-time, which allows for a more exact diagnosis in cases where initial tests warrant further investigation.
UM CRMC is pleased to be one of the first hospitals in the area to offer UroNav, which brings the power of MRI-guided biopsy to diagnosing prostate cancer, and is available at our new outpatient Imaging Center in La Plata.
Through this advanced technology, physicians are now able to go beyond standard tests as needed to target specific areas of the prostate that show potential tumors.
This more precise tool can help physicians find areas of a tumor that may escape detection with primary diagnostic techniques.
By targeting tumors that otherwise would be missed, UroNav has improved the detection and differentiation of high- and low-risk prostate cancers.
Noel Cervino, President and CEO of UM Charles Regional, said, "The new outpatient Imaging Center and the MRI/Ultrasound Fusion Biopsy program are great examples of how our affiliation with the University of Maryland Medical System is bringing university-level health care to Charles County and the Southern Maryland region."
After a patient undergoes an outpatient prostate MRI, the images are sent electronically to the University of Maryland Medical Center in Baltimore where faculty radiologists use DynaCAD. The DynaCAD software allows images to be transferred directly from the MRI into the system to quickly visualize and evaluate suspicious tumors. The UroNav fusion biopsy system uses this critical diagnostic information to provide our skilled urologists with a precisely targeted approach to prostate biopsy.
Dr. Bolivia Davis, Chief of Radiology, said: "Having a 3T MRI at our new outpatient imaging center in La Plata provides state-of-the-art diagnostic capabilities. The images produced are truly superior, and patients can be conveniently scheduled in an outpatient setting."
"We are confident this new technology will bring new hope to patients and equip our healthcare providers with the latest technology to identify and target suspicious prostate tumors" explains Dr. Joseph Collona, urologist and Vice Chief of staff at the hospital.
Dr. Vladimir Kakitelashvili, an urologist who practices at the hospital, also stated: "Other than skin cancer, prostate cancer has become the most common form of cancer in American men and the second-leading cause of cancer death in this population. As 1 in 9 males will be diagnosed with prostate cancer during his lifetime,* the introduction of a MRI/ultrasound fusion biopsy at UM CRMC could not have come at a more opportune time."
About University of Maryland Charles Regional Medical Center
UM Charles Regional Medical Center is a member of the University of Maryland Medical System and serves as regional, not-for-profit, integrated health system serving Charles County and the surrounding areas of Southern Maryland. Our mission is to always provide excellent patient care as measured by the population's health, clinical outcomes, patient satisfaction and cost effectiveness. UM Charles Regional Medical Center will remain the premier place to receive care and the premier place to provide care.
About UM Charles Regional Imaging
University of Maryland Charles Regional Imaging is dedicated to providing nothing less than the very best care to the patient, in a safe, caring and family-centered environment with a remarkable patient experience. Our brand new imaging center offers patients comfort and quality imaging services in a friendly setting. For more information, please visit CharlesRegionalImaging.com.
* American Cancer Society 2018